应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
BLLN BillionToOne, Inc.
盘后交易 11-19 18:40:27 EST
90.20
-1.34
-1.46%
盘后
90.20
+0.00
0.00%
17:08 EST
最高
93.79
最低
89.51
成交量
91.44万
今开
90.85
昨收
91.54
日振幅
4.68%
总市值
43.09亿
流通市值
25.99亿
总股本
4,777万
成交额
8,319万
换手率
3.17%
流通股本
2,882万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
财报前瞻 | BillionToOne, Inc.本季度营收预计增39.57%,机构观点以谨慎乐观为主
财报Agent · 10-28
财报前瞻 | BillionToOne, Inc.本季度营收预计增39.57%,机构观点以谨慎乐观为主
财报前瞻|BillionToOne, Inc.本季度营收预计小幅增长,机构观点偏多
财报Agent · 07-29
财报前瞻|BillionToOne, Inc.本季度营收预计小幅增长,机构观点偏多
BillionToOne任命Ethan Dmitrovsky博士为肿瘤学首席医疗官,主导Northstar医疗战略
美股速递 · 07-20
BillionToOne任命Ethan Dmitrovsky博士为肿瘤学首席医疗官,主导Northstar医疗战略
加载更多
公司概况
公司名称:
BillionToOne, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
BillionToOne, Inc.于2016年作为特拉华州公司开始运营。该公司开发了一种革命性的单分子下一代测序(smNGS)平台,能够以单分子灵敏度检测和精确量化基因靶标。这项创新的核心是其专利的定量计数模板(QCT),该模板可在单个DNA分子水平上进行测量。这项技术突破了医疗保健领域在检测游离DNA中稀疏但具有临床意义的疾病信号方面的一个关键瓶颈。BillionToOne的技术平台已成功应用于一系列开创性的产前和肿瘤学产品,这些产品仅需简单的血液样本即可提供可操作的诊断信息。
发行价格:
--
{"stockData":{"symbol":"BLLN","market":"US","secType":"STK","nameCN":"BillionToOne, Inc.","latestPrice":90.2,"timestamp":1795122000000,"preClose":91.54,"halted":0,"volume":914427,"hourTrading":{"tag":"盘后","latestPrice":90.2,"preClose":90.2,"latestTime":"17:08 EST","volume":3234,"amount":291706.8,"timestamp":1795126109461,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.014638409438496869,"floatShares":28817000,"shares":47774848,"eps":0.917345,"marketStatus":"盘后交易","change":-1.34,"latestTime":"11-19 18:40:27 EST","open":90.85,"high":93.79,"low":89.505,"amount":83188857.86338499,"amplitude":0.04681,"askPrice":95,"askSize":2,"bidPrice":89.3,"bidSize":1,"shortable":0,"etf":0,"ttmEps":0.917345,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1795136400000},"marketStatusCode":4,"adr":0,"listingDate":1762405200000,"exchange":"NASDAQ","adjPreClose":91.54,"preHourTrading":{"tag":"盘前","latestPrice":90.81,"preClose":91.54,"latestTime":"09:29 EST","volume":168,"amount":15544.598832,"timestamp":1795098566123,"change":-0.73,"changeRate":-0.007975,"amplitude":0.024033},"postHourTrading":{"tag":"盘后","latestPrice":90.2,"preClose":90.2,"latestTime":"17:08 EST","volume":3234,"amount":291706.8,"timestamp":1795126109461,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.045341,"impliedVol":0.753,"impliedVolPercentile":0.4},"requestUrl":"/m/hq/s/BLLN","defaultTab":"news","newsList":[{"id":"1194460324","title":"财报前瞻 | BillionToOne, Inc.本季度营收预计增39.57%,机构观点以谨慎乐观为主","url":"https://stock-news.laohu8.com/highlight/detail?id=1194460324","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194460324?lang=zh_cn&edition=full","pubTime":"2026-10-28 12:01","pubTimestamp":1793160113,"startTime":"0","endTime":"0","summary":"BillionToOne, Inc.将于2026年11月04日发布最新季度财报,市场关注收入增速与盈利韧性以及产品结构带来的毛利率表现。市场一致预期本季度BillionToOne, Inc.营收为1.16亿美元,同比增长39.57%;EBIT为0.77千万美元,同比增长4.83%;调整后每股收益为0.15美元,同比下降71.15%。上季度BillionToOne, Inc.营收为1.09亿美元,同比数据未披露;毛利率为70.45%,同比数据未披露;归属母公司股东的净利润为805.40万美元,环比增长率为-55.18%;净利率为7.36%,同比数据未披露;调整后每股收益为0.15美元,同比数据未披露。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻 | BillionToOne, Inc.本季度营收预计增39.57%,机构观点以谨慎乐观为主","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173245394","title":"财报前瞻|BillionToOne, Inc.本季度营收预计小幅增长,机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1173245394","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173245394?lang=zh_cn&edition=full","pubTime":"2026-07-29 11:28","pubTimestamp":1785295724,"startTime":"0","endTime":"0","summary":"BillionToOne, Inc.将于2026年08月05日发布财报,市场关注营收与盈利质量的结构性变化及单项业务的增长延续性。根据市场一致预期,本季度BillionToOne, Inc.预计营收为1.09亿美元,同比数据未披露;预计毛利率未披露;预计净利润或净利率未披露;预计调整后每股收益为0.18美元,同比数据未披露。主营来看,产前产品营收9,652.50万美元,占比89.06%;肿瘤学营收1,072.00万美元,占比9.89%;临床试验支持服务营收114.30万美元,占比1.05%,同比数据未披露。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻|BillionToOne, Inc.本季度营收预计小幅增长,机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190143234","title":"BillionToOne任命Ethan Dmitrovsky博士为肿瘤学首席医疗官,主导Northstar医疗战略","url":"https://stock-news.laohu8.com/highlight/detail?id=1190143234","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190143234?lang=zh_cn&edition=full","pubTime":"2026-07-20 21:02","pubTimestamp":1784552542,"startTime":"0","endTime":"0","summary":"BillionToOne已任命Ethan Dmitrovsky博士担任肿瘤学首席医疗官一职。他将负责领导公司Northstar项目的整体医疗战略。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BLLN"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.billiontoone.com","stockEarnings":[{"period":"1week","weight":-0.1696},{"period":"1month","weight":-0.0939},{"period":"3month","weight":-0.0392},{"period":"6month","weight":0.0654},{"period":"1year","weight":-0.0781},{"period":"ytd","weight":0.1185}],"compareEarnings":[{"period":"1week","weight":-0.039},{"period":"1month","weight":-0.0473},{"period":"3month","weight":-0.0425},{"period":"6month","weight":-0.0207},{"period":"1year","weight":0.1062},{"period":"ytd","weight":0.0708}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BillionToOne, Inc.于2016年作为特拉华州公司开始运营。该公司开发了一种革命性的单分子下一代测序(smNGS)平台,能够以单分子灵敏度检测和精确量化基因靶标。这项创新的核心是其专利的定量计数模板(QCT),该模板可在单个DNA分子水平上进行测量。这项技术突破了医疗保健领域在检测游离DNA中稀疏但具有临床意义的疾病信号方面的一个关键瓶颈。BillionToOne的技术平台已成功应用于一系列开创性的产前和肿瘤学产品,这些产品仅需简单的血液样本即可提供可操作的诊断信息。","exchange":"NASDAQ","name":"BillionToOne, Inc.","nameEN":"BillionToOne, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BillionToOne, Inc.(BLLN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BillionToOne, Inc.(BLLN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BillionToOne, Inc.,BLLN,BillionToOne, Inc.股票,BillionToOne, Inc.股票老虎,BillionToOne, Inc.股票老虎国际,BillionToOne, Inc.行情,BillionToOne, Inc.股票行情,BillionToOne, Inc.股价,BillionToOne, Inc.股市,BillionToOne, Inc.股票价格,BillionToOne, Inc.股票交易,BillionToOne, Inc.股票购买,BillionToOne, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BillionToOne, Inc.(BLLN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BillionToOne, Inc.(BLLN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}